Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Armour Thyroid vs Synthetic T4 in Primary Hypothyroidism
NCT06345339Phase 3Active, not recruiting
- Sponsor
- AbbVie Inc.
- Start
- Apr 2024
- Primary completion
- Sep 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of thyroid, porcine in primary hypothyroidism (PH), sponsored by AbbVie Inc.. Started Apr 2024; status: active, not recruiting.
02
Drugs
thyroid, porcine
03
Conditions
primary hypothyroidism (PH)
Beyond the preview
Go deeper on NCT06345339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06345339.